TABLE A2.
Baseline Characteristics of mUC-Non-EV
| Characteristic | Nonamplified (n = 76) | Amplified (n = 27) | P a |
|---|---|---|---|
| Sex, No. (%) | .001 | ||
| Male | 53 (70) | 27 (100) | |
| Female | 23 (30) | 0 (0) | |
| Age, years | .069 | ||
| Median (IQR) | 67 (56-72) | 71 (62-75) | |
| Range | 39-82 | 25-85 |
NOTE. Significant P values are highlighted in bold.
Abbreviation: mUC-Non-EV, metastatic urothelial cancer-non enfortumab vedotin.
Pearson's chi-squared test; Wilcoxon rank-sum test.